Bioventus Inc (BVS)
10.68
+0.03
(+0.28%)
USD |
NASDAQ |
Dec 24, 16:00
Bioventus Free Cash Flow: 29.05M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp | 1.892B |
| Insulet Corp | 218.20M |
| Perspective Therapeutics Inc | -40.58M |
| Xtant Medical Holdings Inc | -17.28M |
| Catheter Precision Inc | -8.381M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 10.32M |
| Cash from Investing (Quarterly) | -0.064M |
| Cash from Financing (Quarterly) | 0.362M |
| Free Cash Flow Per Share (Quarterly) | 0.1571 |
| Free Cash Flow to Equity (Quarterly) | 9.947M |
| Free Cash Flow to Firm (Quarterly) | 20.95M |
| Free Cash Flow Yield | 4.25% |